• Go to navigation
  • Go to content
AstraZeneca

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca United States

Main navigation

  • Home
  • Our medicines
  • Diseases and conditions
  • Responsibility
  • Community support
  • Help affording your medicines
  • Research & development
  • Healthcare professionals
  • HealthCare Foundation
  • Careers
  • About AstraZeneca US
    • Our company
    • AZ on the issues
    • Investors
    • Newsroom
      • All news
      • Corporate news
      • Financial news
      • Product news
      • Research news
      • Media resources
    • US web sites
    • Social media sites
    • Contact us

You are here

  • Home
  • About AstraZeneca US
  • Newsroom
  • All news

  • U.S. Food and Drug Administration approves ONGLYZA™ (saxagliptin) for the treatment of type 2 diabetes mellitus in adults

Published date :
Jul 31, 2009
Expired date :
Jul 31, 2010

July 31, 2009 – Wilmington, DE – FDA approves ONGLYZA™ (saxagliptin) for type 2 diabetes mellitus in adults. 

  •  Read full release 

Page tools

  • Print
  • Bookmark this page
  • Subscribe to RSS news feed

Stay connected with us

Stay connected with us on our social media sites

  • Stay connected with us on our social media sites

Legal notices

  • Legal Information
  • Privacy Statement
  • © AstraZeneca 2010